Please try another search
Plandai Biotechnology, Inc., through its subsidiaries, is engaged in the bio-pharmaceutical business. It grows the green tea used in its Phytofare Catechin production, a 3,000-hectare estate it operates under approximately 50-years lease in the Mpumalanga province of South Africa. It uses an extraction process that is engineered to yield bioavailable products of pharmaceutical-grade purity. It offers Phytofare Catechin Complex, a green-tea derived extract and a commercial product in the Phytofare brand. Its principle holdings consist of land, farms and infrastructure in South Africa. Its extracts include gallate catechins from green tea, such as catechin gallate (CG), epigallocatechin gallate (EGCG), gallocatechin gallate (GCG) and epicatechin gallate (ECG), and carotenoids (lycopene) from tomatoes, as well as citrus bioflavonoids and limonoids. It manufactures and formulates the Pheroid technology for entrapped Phytofare extracts.
Name | Age | Since | Title |
---|---|---|---|
Daron Baylis Duffield | 70 | 2001 | Co-Founder & Director |
Thomas J. Matula | 60 | 2012 | Chairman of the Scientific Board |
Volker Boehm | - | 2012 | Member of Scientific Board |
Roger Baylis-Duffield | 78 | 2001 | Co-Founder, Chairman and Chief Executive Officer |
Callum Baylis-Duffield | 36 | 2013 | President, Chief Operating Officer and Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review